Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Jul 19;293(6540):168–169. doi: 10.1136/bmj.293.6540.168

Retrovirus infections among patients treated in Britain with various clotting factors.

R Cheinsong-Popov, R S Tedder, T O'Connor, S Clayden, A Smith, J Craske, R Weiss
PMCID: PMC1340907  PMID: 3015319

Abstract

At the end of 1984 a collaborative survey was carried out to determine the prevalence of infection with human T cell lymphotropic virus type III/lymphadenopathy associated virus (HTLV-III/LAV) and HTLV-I among 584 recipients of various blood products in Britain at that time. In 204 cases yearly point prevalence figures for infection were also obtained for 1978 to 1983. In 1984, 215 of 315 patients (68%) who had received commercial concentrate for haemophilia A were identified as positive for anti-HTLV-III/LAV as compared with only 18 of 166 patients (11%) given British concentrate alone for this disease. This difference was further emphasised by the yearly point prevalence rates: seroconversion began in 1980 among recipients of commercial concentrate, but not until 1983 did such an instance occur among recipients of British concentrate. Any conclusions must remain speculative, but possibly seropositivity among haemophiliacs may not carry so grave a prognosis as previously thought.

Full text

PDF
168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball S. E., Hows J. M., Worsley A. M., Luzzatto L., Chu A. C., Meacham R., Morris J., Cheingsong-Popov R., Weiss R. A., Tedder R. Seroconversion of human T cell lymphotrophic virus III (HTLV-III) in patients with haemophilia: a longitudinal study. Br Med J (Clin Res Ed) 1985 Jun 8;290(6483):1705–1706. doi: 10.1136/bmj.290.6483.1705-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carne C. A., Weller I. V., Sutherland S., Cheingsong-Popov R., Ferns R. B., Williams P., Mindel A., Tedder R., Adler M. W. Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Lancet. 1985 Jun 1;1(8440):1261–1262. doi: 10.1016/s0140-6736(85)92324-4. [DOI] [PubMed] [Google Scholar]
  3. Cheingsong-Popov R., Weiss R. A., Dalgleish A., Tedder R. S., Shanson D. C., Jeffries D. J., Ferns R. B., Briggs E. M., Weller I. V., Mitton S. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet. 1984 Sep 1;2(8401):477–480. doi: 10.1016/s0140-6736(84)92562-5. [DOI] [PubMed] [Google Scholar]
  4. Clapham P., Nagy K., Weiss R. A. Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera. Proc Natl Acad Sci U S A. 1984 May;81(9):2886–2889. doi: 10.1073/pnas.81.9.2886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuchs D., Dierich M. P., Hausen A., Hengster P., Reibnegger G., Schulz T., Werner E. R., Wachter H. Are homosexuals less at risk of AIDS than intravenous drug abusers and haemophiliacs? Lancet. 1985 Nov 16;2(8464):1130–1130. doi: 10.1016/s0140-6736(85)90722-6. [DOI] [PubMed] [Google Scholar]
  6. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  7. Ludlam C. A., Tucker J., Steel C. M., Tedder R. S., Cheingsong-Popov R., Weiss R. A., McClelland D. B., Philp I., Prescott R. J. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet. 1985 Aug 3;2(8449):233–236. doi: 10.1016/s0140-6736(85)90288-0. [DOI] [PubMed] [Google Scholar]
  8. Mortimer P. P., Jesson W. J., Vandervelde E. M., Pereira M. S. Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84. Br Med J (Clin Res Ed) 1985 Apr 20;290(6476):1176–1178. doi: 10.1136/bmj.290.6476.1176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Okochi K., Sato H., Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984;46(5):245–253. doi: 10.1111/j.1423-0410.1984.tb00083.x. [DOI] [PubMed] [Google Scholar]
  10. Tedder R. S., Shanson D. C., Jeffries D. J., Cheingsong-Popov R., Clapham P., Dalgleish A., Nagy K., Weiss R. A. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet. 1984 Jul 21;2(8395):125–128. doi: 10.1016/s0140-6736(84)91046-8. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES